CoChat

Effects of trypsin and pepsin detection on chronic otitis media with effusion

Open access
Zhao, Zeqi, Han, Zhengzhong, Shao, Yudi, Tang, Tingting, Wang, Caiji, Xu, Bing, Zhao, Zhenlu, Shi, Xi, Jin, Dan, Li, Wei · 2024 · Heliyon

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index; none of the 12 sources its claims cite is checked for support yet.

Abstract

Chronic otitis media with effusion (COME) is a common cause of hearing loss in children and adults. Laryngopharyngeal reflux (LPR) is often overlooked in the clinical management of COME complicated by LPR. This study aimed to investigate the presence and concentration of trypsin and pepsin in the middle ear effusion (MEE), as well as the recurrence rate of otitis media with effusion (OME) in COME patients with trypsin-/pepsin-positive MEE after acid-suppressive treatment (AST). In this study, trypsin and pepsin were found in the MEE of COME patients. Follow-up results showed that the recurrence rate of OME within 1 year was significantly lower in the AST group than in the non-AST group. Taken together, patients with COME can be offered pepsin detection of MEE, and if the pepsin test is positive, acid-suppressing drugs such as proton pump inhibitors could be recommended to prevent the recurrence of OME.

Overview

CoChat Summary

TL;DR

In a prospective cohort of 270 patients with chronic otitis media with effusion (COME), trypsin and pepsin were detected in middle ear effusion (MEE), with higher positivity and concentrations in children than adults. Among pepsin/trypsin-positive patients, 8 weeks of acid-suppressive treatment (AST) was associated with a significantly lower 1-year recurrence rate of otitis media with effusion (OME) than no AST.

Key findings

  • Trypsin and pepsin were present in MEE of COME patients; overall prevalence was 39.63 % (107/270). Control group RSI and Western blot (WB) results were both negative.
  • WB positivity rates were higher in children than adults for pepsin (47.5 % vs 33.3 %, p < 0.05) and trypsin (41.7 % vs 23.3 %, p < 0.01); RSI positivity did not differ significantly (25 % vs 32.7 %).
  • ELISA concentrations in children were pepsin 83.1 (71.3, 89.5) ng/mL and trypsin 401.2 (369.8, 462.5) ng/mL; in adults, pepsin 55.2 [19.3] ng/mL and trypsin 304.6 (289.5, 397.5) ng/mL. Concentrations were higher in children than adults (P < 0.05), and serous vs mucous MEE type was not significantly associated with trypsin or pepsin concentration.
  • One-year OME recurrence was lower in AST vs non-AST groups: children 13.8 % vs 71.4 % and adults 8 % vs 76 % (both p < 0.0001). Tympanic membrane healing time was shorter with AST (1.1 vs 1.6 months, p < 0.001), and suppurative otitis media, hearing loss, and tinnitus were less frequent in the AST group.

Methods

  • Prospective cohort study at the Department of Otorhinolaryngology-Head and Neck Surgery, Affiliated Hospital of Xuzhou Medical University, China, from January 2018 to December 2023. Included 270 COME patients (120 children, 150 adults) and 50 healthy controls; inclusion required OME duration >3 months, conductive hearing loss, B-type tympanogram, evidence of MEE, and negative MEE bacterial culture.
  • MEE was collected, classified as serous or mucous, and tested for pH; all participants completed the Reflux Symptom Index (RSI). WB detected trypsin and pepsin, and ELISA measured concentrations in WB-positive samples. Pepsin- or trypsin-positive patients were randomized by drawing cards to 8-week proton pump inhibitor AST or follow-up, with monthly follow-up and 1-year recurrence assessment.
  • Statistical analysis used SPSS version 25.0; Shapiro-Wilk test, independent samples t-test or Mann-Whitney test, and Chi-square test, with significance thresholds reported as *p < 0.05, p < 0.01, *p < 0.001, p < 0.0001.

Limitations

  • The paper states that the specific pathogenesis requires further research and investigation; it does not include a dedicated limitations section.
  • Evident from the text: the study was single-center, and the control group consisted only of healthy adults aged 18–50 years, with no child controls; control samples were nasopharyngeal swabs rather than MEE.
  • Evident from the text: RSI is a subjective measure, and randomization by drawing cards is described without reported blinding, allocation concealment, or placebo control.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.heliyon.2024.e40112

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Otoscopic signs and effusion samples of serous and mucous groups. (A) Representative endoscopic sign of the serous group. (B) Representative endoscopic sign of the mucous group. (C) On the left is an effusion sample from the serous group and on the right is an effusion sample from the mucous group.
Fig. 1 Otoscopic signs and effusion samples of serous and mucous groups. (A) Representative endoscopic sign of the serous group. (B) Representative endoscopic sign of the mucous group. (C) On the left is an effusion sample from the serous group and on the right is an effusion sample from the mucous group.CC BY-NC-ND · PubMed Central
Fig. 2 Representative WB images of trypsin and pepsin in the MEE of 7 COME volunteers.
Fig. 2 Representative WB images of trypsin and pepsin in the MEE of 7 COME volunteers.CC BY-NC-ND · PubMed Central
Fig. 3 Comparison of the concentrations of (A) pepsin and (B) trypsin in MEE between child and adult group by ELISA.
Fig. 3 Comparison of the concentrations of (A) pepsin and (B) trypsin in MEE between child and adult group by ELISA.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 9 Not checked · 39 Own results and interpretations

30 more claims

Create a free account to see all 48 claims and to verify the 12 references still open.

See all claims — free account
  • It may state two separate claims as one. 5
  • Probably not a substantial claim. 7
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 22 references

Metadata

Authors
Zhao, Z., Han, Z., Shao, Y., Tang, T., Wang, C., Xu, B., Zhao, Z., Shi, X., Jin, D., & Li, W.
Affiliations
  • Xuzhou Children Hospital (CN)
  • Xuzhou Medical College (CN)
  • Hainan University (CN)
Corresponding author
  • Han, Zhengzhong
  • Shao, Yudi
  • Tang, Tingting
  • Wang, Caiji
  • Xu, Bing
  • Zhao, Zhenlu
  • Shi, Xi
  • Jin, Dan
  • Li, Wei
Venue
Heliyon
Publisher
Elsevier BV
Published
2024-11
Volume
10
Issue
21
Pages
e40112
ISSN
2405-8440 (ISSN-L)
OpenAlex
W4404028975
Cited by
8
References
21
Citations by year
2026: 4 · 2025: 4
FWCI
2.74
Type
journal article
Language
en
Open access
Licence
Locations
  • Heliyon (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Jiangsu Provincial Health Commission (H2023032)
  • Xuzhou Science and Technology Bureau (KC21249, KC23039, KC22104, KC21050)
  • Jiangsu Commission of Health
  • Xuzhou Medical University
Topics
  • Health Sciences › Medicine › Otorhinolaryngology › Ear Surgery and Otitis Media
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Health Sciences › Medicine › Oncology › Ear and Head Tumors
Keywords
chronic otitis media with effusion, middle ear effusion, trypsin, pepsin, laryngopharyngeal reflux, proton pump inhibitors, otitis media with effusion recurrence, hearing loss

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of trypsin and pepsin detection on chronic otitis media with effusion. https://app.cochat.ai/papers/10.1016/j.heliyon.2024.e40112
The paper
Zhao, Z., Han, Z., Shao, Y., Tang, T., Wang, C., Xu, B., Zhao, Z., Shi, X., Jin, D., & Li, W. (2024). Effects of trypsin and pepsin detection on chronic otitis media with effusion. Heliyon. https://doi.org/10.1016/j.heliyon.2024.e40112

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.